Future studies will consider knockdown or pharmacological approaches to test the contributions of key pruriceptors, such as MrgprA3 and MrgprD (2, 4), natriuretic polypeptide b receptor (9), and gastrin-releasing peptide receptor (8) in the CTCL model. Here, MRGPRD is linked to primary cutaneous T-cell non-Hodgkin lymphoma.